Table 2 Management and outcome data of reported cases of DSF after gastrectomy for malignant disease
Author/Year | Management | Outcomes | Hospital stay, | Healing time, | DSF-related | |||||
|---|---|---|---|---|---|---|---|---|---|---|
median days (range) | median days (range) | mortality rate (%) | ||||||||
Conservative | Endoscopic | Percutaneous | Surgical | |||||||
Transhepatic biliary diversion | Abscess/Abdominal drainage | Duodenostomy | ||||||||
Garden et al./1988 [9] | 5 | 0 | 0 | 5 | 0 | 0 | Conservative: 5/5 solved | NA | 35 (17–71)a | 0% (0/5) |
Endoscopic: −/− | ||||||||||
Percutaneous: 5/5 solved | ||||||||||
Surgical: −/− | ||||||||||
Bloch et al./1989 [10] | 0 | 1 | 0 | 0 | 0 | 0 | Conservative: −/− | NA | 35 | 0% (0/1) |
Endoscopic: 1/1 solved | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: −/− | ||||||||||
Kyzer et al./1997 [11] | 1 | 0 | 0 | 0 | 0 | 1 | Conservative: 1/1 solved | NA | NA | 50% (1/2) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 0/1 solved | ||||||||||
Wong et al./2000 [12] | 0 | 1 | 0 | 0 | 0 | 0 | Conservative: −/− | NA | 2 | 0% (0/1) |
Endoscopic: 1/1 solved | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: −/− | ||||||||||
Oh et al./2009 [13] | 0 | 0 | 0 | 0 | 0 | 5 | Conservative: −/− | NA | 18 (10–28)a | 0% (0/5) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 5/5 solved | ||||||||||
Lee et al./2009 [14] | 0 | 1 | 0 | 0 | 0 | 0 | Conservative: −/− | 34 | 17 | 0% (0/1) |
Endoscopic: 1/1 solved | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: −/− | ||||||||||
Cozzaglio et al./2010 [5] | 51 | 0 | 4 | 15 | 2 | 27 | Conservative: NA/NA | 21 (7–65) without complications; 31 (1–1035) with complications | 19 (1–1035) | 16.2% (11/68) |
Endoscopic: −/− | ||||||||||
Percutaneous: NA/NA | ||||||||||
Surgical: NA/NA | ||||||||||
Hur et al./2010 [15] | 0 | 0 | 0 | 0 | 4 | 1 | Conservative: −/− | 48 (30–158) | 21 (12–44) | 0% (0/4) |
Endoscopic: −/− | ||||||||||
Percutaneous: 3/4 solved | ||||||||||
Surgical: 1/1 solved | ||||||||||
Cozzaglio et al./2011 [16] | 6 | 0 | 6 | 5 | 0 | 0 | Conservative: 0/6 solved | 63 (40–167) | 63 (40–621) | 50% (3/6) |
Endoscopic: −/− | ||||||||||
Percutaneous: 0/5 PAD; 3/6 PTBD-OD solved | ||||||||||
Surgical: −/− | ||||||||||
Curcio et al./2012 [17] | 0 | 1 | 1 | 1 | 0 | 0 | Conservative: −/− | NA | 60 | 0% (0/1) |
Endoscopic: 1/1 solved | ||||||||||
Percutaneous: 0/2 solved | ||||||||||
Surgical: −/− | ||||||||||
Oh et al./2013 [18] | 0 | 0 | 0 | 0 | 10 | 0 | Conservative: −/− | 32 (18–57) | 51 (23–89) | 0% (0/10) |
Endoscopic: −/− | ||||||||||
Percutaneous: 10/10 solved | ||||||||||
Surgical: −/− | ||||||||||
Blouhos et al./2013 [19] | 0 | 0 | 0 | 0 | 0 | 1 | Conservative: −/− | 36 | 45 | 0% (0/1) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 1/1 solved | ||||||||||
Vasiliadis et al./2014 [20] | 0 | 0 | 0 | 0 | 0 | 1 | Conservative: −/− | 17 | 15 | 0% (0/1) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 1/1 solved | ||||||||||
Kim et al./2014 [21] | 3 | 0 | 0 | 0 | 0 | 10 | Conservative: 3/3 solved | 26 (12–140) | 11.7 (8–18) conservative group, 57.3 (14–134) surgical groupa | 15.4% (2/13) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 8/10 solved | ||||||||||
Orsenigo et al./2014 [3] | 11 | 0 | 3 | 5 | 0 | 13 | Conservative: 11/11 solved | NA | 31.2 ± 19.7 (conservative, PTBD and drainage); 45.2 ± 57.4 (surgical)a | 9.4% (3/32) |
Endoscopic: −/− | ||||||||||
Percutaneous: 8/8 solved | ||||||||||
Surgical: 10/13 solved | ||||||||||
Cornejo et al./2016 [22] | 5 | 0 | 0 | 0 | 0 | 8 | Conservative: 5/5 solved | 39.5 (26–65) conservative; 34.3 (13–84) surgicala | NA | 46.2% (6/13) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 2/8 solved | ||||||||||
Cozzaglio et al./2016 [4] | 0 | 0 | 0 | 0 | 0 | 75 | Conservative: −/− | 39 (22–68) solved; 32 (18–41) overall | 28.5 (18–60) 1 surgical operation; 63 (50–82) > 1 surgical operation | 28% (21/75) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 54/75 solved | ||||||||||
Ali et al./2016 [7] | 5 | 0 | 0 | 11 | 3 | 5 | Conservative: 5/5 solved | 22 (11–96) | NA | 0% (0/24) |
Endoscopic: −/− | ||||||||||
Percutaneous: 14/14 solved | ||||||||||
Surgical: 5/5 solved | ||||||||||
Paik et al./2016 [6] | 6 | 0 | 6 | 1 | 0 | 3 | Conservative: 6/6 solved | 27.5 (15–54) solved group | NA | 12,5% (2/16) |
Endoscopic: −/− | ||||||||||
Percutaneous: 6/7 solved | ||||||||||
Surgical: 2/3 solved | ||||||||||
Ramos et al./2018 [2] | 8 | 0 | 0 | 0 | 0 | 7 | Conservative: 5/8 solved | NA | NA | 40% (6/15) |
Endoscopic: −/− | ||||||||||
Percutaneous: −/− | ||||||||||
Surgical: 4/7 solved | ||||||||||